Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Change in Other Operating Liabilities (2024 - 2026)

Updated

Impact Biomedical (IBO) posted Change in Other Operating Liabilities of $293,000 for Q3 2026.

Analysis

Impact Biomedical (IBO) Change in Other Operating Liabilities (2024 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Change in Other Operating Liabilities at Impact Biomedical was $1.05 million.

  • The Q3 2026 figure stands as the lowest quarterly Change in Other Operating Liabilities since Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.69 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -34.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -113.00 Mn
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00 293,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 293,000.00
Jun 30, 2025 260,000.00
Mar 31, 2025 271,000.00
Mar 31, 2024 230,000.00
API Access

Impact Biomedical Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=IBO&period=max&api_key=YOUR_API_KEY